Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Gastric Cancer

Free Subscription Articles published in J Gastroenterol Hepatol Retrieve available abstracts of 87 articles: HTML format

Single Articles

August 2026
1. LUO W, Jiang L, Hu X
   Metabolic Reprogramming Drives Platinum Resistance in Gastric Cancer: From ENO1/PDK3 to ATF4-Autophagy Compensation.
   J Gastroenterol Hepatol. 2026 Aug 31. doi: 10.1111/jgh.70708.
   PubMed    
   
   
   
2. HOU S, Sang M, Wang Y, Que H, et al
   Integrated Transcriptomic Analysis and Machine Learning Identify THY1 as a Key Regulator of Cancer-Associated Fibroblast Infiltration, Promoting Malignant Progression and Immune Escape in Gastric Cancer.
   J Gastroenterol Hepatol. 2026 Aug 21. doi: 10.1111/jgh.70586.
   PubMed     Abstract available
   
   
   
3. CHEN J, Xu T, Lin C
   TREM1 Blockade Reprograms Tumor-Associated Macrophages and Improves Anti-PD-1 Efficacy in Gastric Cancer.
   J Gastroenterol Hepatol. 2026 Aug 16. doi: 10.1111/jgh.70659.
   PubMed     Abstract available
   
   
   
4. RAZA F, Jabbar D, Ullah FNUM, Khan M, et al
   Re: "Differences in the Gastric Microbiotas of Neighboring Populations With Divergent Risks of Gastric Cancer" by Caguazango et al.
   J Gastroenterol Hepatol. 2026 Aug 13. doi: 10.1111/jgh.70665.
   PubMed    
   
   
   
5. LI H, Sun P, Wang J, Wang Y, et al
   From Chronic Atrophic Gastritis to Low-Grade Intraepithelial Neoplasia: A Proteomic Study on the Sequential Progression of Gastric Precancerous Lesions.
   J Gastroenterol Hepatol. 2026;41:2393-2404.
   PubMed     Abstract available
   
   
   July 2026
6. YANG F, Zhang X, Ji J, Li S, et al
   E3 Ubiquitin Ligase MDM2 Promotes Growth and CD8(+) T Cell Dysfunction in Gastric Cancer Through Degradation of SST.
   J Gastroenterol Hepatol. 2026 Jul 31. doi: 10.1111/jgh.70613.
   PubMed     Abstract available
   
   
   
7. SUN X, Chen Y, Liu K, Si Y, et al
   YTHDF3 Promotes the Progression of Gastric Cancer by Activating the Wnt/beta-Catenin Signaling Pathway via Targeting NEK7.
   J Gastroenterol Hepatol. 2026 Jul 30. doi: 10.1111/jgh.70612.
   PubMed     Abstract available
   
   
   
8. CAGUAZANGO JC, Vinasco K, Simovic I, Caicedo YY, et al
   Differences in the Gastric Microbiotas of Neighboring Populations With Divergent Risks of Gastric Cancer.
   J Gastroenterol Hepatol. 2026 Jul 21. doi: 10.1111/jgh.70587.
   PubMed     Abstract available
   
   
   
9. WATANABE K, Fukuda S, Kubota D, Yamamichi N, et al
   Five-Year Unified Risk Prediction Model for Gastric and Esophageal Cancer Based on Nationwide Health Check-Up Data in Japan: J-GESS Score.
   J Gastroenterol Hepatol. 2026;41:2073-2081.
   PubMed     Abstract available
   
   
   May 2026
10. KOUNTOURAS J, Kazakos E, Hourpouliadis I, Vardaka E, et al
    Helicobacter pylori and Porphyromonas gingivalis Infections as Potential Risk Predictors for Gastric Cancer and Two Types of Esophageal Cancer.
    J Gastroenterol Hepatol. 2026 May 31. doi: 10.1111/jgh.70464.
    PubMed    
    
    
    
11. ABEDEEN ZU, Jan A, Alam I, Khan M, et al
    Re-Evaluating the J-GESS Score: A 5-Year Unified Risk Prediction Model for Gastric Cancer and Esophageal Squamous Cell Carcinoma.
    J Gastroenterol Hepatol. 2026 May 29. doi: 10.1111/jgh.70474.
    PubMed    
    
    
    
12. YAR S, Ashfaq T, Nag IS, Ahlawat D, et al
    Mechanism, Association, and Actionable Evidence: Comment on Engin et al. on Helicobacter pylori and Extra-Gastric Cancer Risk.
    J Gastroenterol Hepatol. 2026 May 15. doi: 10.1111/jgh.70432.
    PubMed    
    
    
    April 2026
13. ENGIN ED, Engin AB, Engin A
    Immune Evasion of Helicobacter pylori and Extra-Gastric Cancer Risk.
    J Gastroenterol Hepatol. 2026 Apr 13. doi: 10.1111/jgh.70376.
    PubMed     Abstract available
    
    
    
14. LIU C, Liao M
    Concerns Regarding Real-World Applicability of Automated Microvascular Blood Flow Analysis in Early Gastric Cancer.
    J Gastroenterol Hepatol. 2026 Apr 9. doi: 10.1111/jgh.70384.
    PubMed    
    
    
    March 2026
15. ASGHAR F, Rana RUR, Ali MH
    "Commentary on Akazawa et al.: Advancing Automated Microvascular Blood Flow Analysis in Early Gastric Cancer _ Promise and Pitfalls.".
    J Gastroenterol Hepatol. 2026 Mar 29. doi: 10.1111/jgh.70382.
    PubMed    
    
    
    
16. ELIA A
    Critique on "Development and Validation of a New Prediction Criteria for Neoadjuvant Chemotherapy Response in Locally Advanced Gastric Cancer Based on Ferroptosis-Related Biomarkers".
    J Gastroenterol Hepatol. 2026 Mar 16. doi: 10.1111/jgh.70356.
    PubMed    
    
    
    
17. TSAO C, Ma Y, Wang F, Yu H, et al
    IKZF3 Promotes Gastric cancer Progression and Oxaliplatin Resistance via PI3K/AKT/mTOR Activation.
    J Gastroenterol Hepatol. 2026 Mar 12. doi: 10.1111/jgh.70331.
    PubMed     Abstract available
    
    
    
18. HUA T, Zhai L
    A Critical Appraisal of a Ferroptosis-Base Prediction Model for Neoadjuvant Chemotherapy in Gastric Cancer.
    J Gastroenterol Hepatol. 2026 Mar 11. doi: 10.1111/jgh.70250.
    PubMed    
    
    
    February 2026
19. YAO YH, Dou QX, Li SN, Liu L, et al
    Comment on "Scissor-Type Knife Improves Trainee's Self-Completion of Endoscopic Submucosal Dissection for Early Gastric Cancer".
    J Gastroenterol Hepatol. 2026 Feb 24. doi: 10.1111/jgh.70323.
    PubMed    
    
    
    
20. HUANG Y, Xie S, Yan C, Zhang J, et al
    Neutrophil-Mediated Mechanisms and Therapeutic Reversibility of Gastric Intestinal Metaplasia.
    J Gastroenterol Hepatol. 2026;41:586-605.
    PubMed     Abstract available
    
    
    January 2026
21. MA Y, Zhang Y, Hu X, Jiang Z, et al
    Identifying a Novel Six-LncRNA Signature Evaluates Survival and Reveals AC129507.1 as the m(6)A-Target to Regulate Ferroptosis in Gastric Cancer.
    J Gastroenterol Hepatol. 2026 Jan 23. doi: 10.1111/jgh.70255.
    PubMed     Abstract available
    
    
    
22. UYAMA K, Iwagami H, Nakatani Y, Uenoyama Y, et al
    Large, White Globe Appearance-Like Endoscopic Findings: Stomach Lymphatic Invasion Distant From Advanced Gastric Cancer.
    J Gastroenterol Hepatol. 2026 Jan 21. doi: 10.1111/jgh.70256.
    PubMed     Abstract available
    
    
    
23. FUKUI H, Dohi O, Iwai N, Seya M, et al
    Scissor-Type Knife Improves Trainee's Self-Completion of Endoscopic Submucosal Dissection for Early Gastric Cancer.
    J Gastroenterol Hepatol. 2026 Jan 6. doi: 10.1111/jgh.70216.
    PubMed     Abstract available
    
    
    
24. LUO SB, Liu ZQ, Wang L, Zhang YQ, et al
    Feasibility and Safety of Endoscopic Full-Thickness Resection for Gastric Submucosal Tumors With Extraluminal Growth.
    J Gastroenterol Hepatol. 2026;41:260-267.
    PubMed     Abstract available
    
    
    
25. JIA Z, Xiong K, Zhou Y, Chen R, et al
    Integrated Multiomics Analysis and Experimental Validation Identify ITPRIPL1 as an Immunoregulatory and Prognostic Biomarker in Gastric Adenocarcinoma.
    J Gastroenterol Hepatol. 2026;41:231-247.
    PubMed     Abstract available
    
    
    December 2025
26. ICHITA C, Kusano C, Gotoda T, Hagiwara Y, et al
    Prevalence and Incidence of Gastric Cancer Among Helicobacter pylori-Naive Individuals in Japan: A Systematic Review and Meta-Analysis.
    J Gastroenterol Hepatol. 2025 Dec 29. doi: 10.1111/jgh.70217.
    PubMed     Abstract available
    
    
    
27. CHIANG TH, Chuang SL, Chu TC, Lee YC, et al
    Population-Based Helicobacter pylori Screening for Gastric Cancer Prevention: Opportunities and Challenges in Asia.
    J Gastroenterol Hepatol. 2025 Dec 22. doi: 10.1111/jgh.70209.
    PubMed     Abstract available
    
    
    November 2025
28. DENG X, Hu Y, Yang X, Luo X, et al
    FTO Upregulates GLG1 Expression via m(6)A Methylation Modification to Facilitate Gastric Cancer Cell Migration and Invasion.
    J Gastroenterol Hepatol. 2025 Nov 24. doi: 10.1111/jgh.70170.
    PubMed     Abstract available
    
    
    
29. LIU G, Liu Y, Zhao H, Sun J, et al
    m6A-Modified BASP1 Regulates IL6 Expression to Induce TAM Infiltration to Promote Gastric Cancer Progression.
    J Gastroenterol Hepatol. 2025 Nov 18. doi: 10.1111/jgh.70149.
    PubMed     Abstract available
    
    
    
30. YAO YH, Wang ZH, Shen XJ, Liu L, et al
    Underwater Endoscopic Mucosal Resection for Early Gastric Cancer: An Endoscopic Treatment Method Worthy of Study.
    J Gastroenterol Hepatol. 2025 Nov 6. doi: 10.1111/jgh.70158.
    PubMed    
    
    
    October 2025
31. SHEN M, Cai Q, Wang R, Zhang F, et al
    Development and Validation of a New Prediction Criteria for Neoadjuvant Chemotherapy Response in Locally Advanced Gastric Cancer Based on Ferroptosis-Related Biomarkers.
    J Gastroenterol Hepatol. 2025 Oct 26. doi: 10.1111/jgh.70124.
    PubMed     Abstract available
    
    
    
32. AKAZAWA Y, Ueyama H, Nakamura S, Uemura Y, et al
    Usefulness of Automated Analysis System for Microvascular Blood Flow Rate Using Magnifying Endoscopy in Early Gastric Cancer: A Multicenter Retrospective Study (With Video).
    J Gastroenterol Hepatol. 2025 Oct 6. doi: 10.1111/jgh.70102.
    PubMed     Abstract available
    
    
    
33. ARIF S, Fatima R, Rana RUR
    Evaluating the Quality of Life in Gastric Cancer Survivors: Reflections on Jeon et al.'s Nationwide Study.
    J Gastroenterol Hepatol. 2025 Oct 4. doi: 10.1111/jgh.70108.
    PubMed    
    
    
    
34. JESWANI HK, Hassnain SF, Maheshwari S
    Letter to the Editor: Factors Affecting Low Health-Related Quality of Life and Health Issues in Gastric Cancer Survivors: A Propensity Score-Matched, Nationwide Study.
    J Gastroenterol Hepatol. 2025 Oct 2. doi: 10.1111/jgh.70103.
    PubMed    
    
    
    
35. VEERASATHIAN T, Rattanapitoon SK, Rattanapitoon NK
    Comment on "Factors Affecting Low Health-Related Quality of Life and Health Issues in Gastric Cancer Survivors: A Propensity Score-Matched, Nationwide Study".
    J Gastroenterol Hepatol. 2025 Oct 1. doi: 10.1111/jgh.70106.
    PubMed    
    
    
    September 2025
36. ANDO Y, Uedo N, Tani Y, Ueda T, et al
    Usefulness of Underwater Endoscopic Mucosal Resection Compared With Conventional Endoscopic Mucosal Resection for Early Gastric Cancer.
    J Gastroenterol Hepatol. 2025 Sep 3. doi: 10.1111/jgh.70062.
    PubMed     Abstract available
    
    
    
37. ISHIDA T, Yamaguchi T, Yoshida T, Kobayashi S, et al
    Evaluating Malignant Potential of Gastric Adenomas: The Role of Endoscopic Features and Genetic Alterations.
    J Gastroenterol Hepatol. 2025;40:2282-2289.
    PubMed     Abstract available
    
    
    August 2025
38. JEON HJ, Choi HS, Lee JM, Kim ES, et al
    Factors Affecting Low Health-Related Quality of Life and Health Issues in Gastric Cancer Survivors: A Propensity Score-Matched, Nationwide Study.
    J Gastroenterol Hepatol. 2025 Aug 7. doi: 10.1111/jgh.70000.
    PubMed     Abstract available
    
    
    
39. IWASAKI M, Matsumura T, Okimoto K, Ohyama Y, et al
    Long-Term Outcomes of Gastric Subepithelial Lesion of < 2 cm and Risk Factors for Tumor Growth.
    J Gastroenterol Hepatol. 2025;40:1926-1932.
    PubMed     Abstract available
    
    
    July 2025
40. WAJEEHA FNU, Raza S, Toor Z
    Comments on Programmed Cell Death Signature and THBS1 in Gastric Cancer: Advancing Toward Translational Clarity.
    J Gastroenterol Hepatol. 2025 Jul 24. doi: 10.1111/jgh.70035.
    PubMed    
    
    
    June 2025
41. WANG J, Li D, Ye F, Li J, et al
    Global Epidemiology of Early-Onset Digestive System Malignancy: A Systematic Analysis for the Global Burden of Disease Study 2021.
    J Gastroenterol Hepatol. 2025;40:1525-1535.
    PubMed     Abstract available
    
    
    
42. ALI M, Srour L, Bitar M, Karam K, et al
    Current Guidelines and Advances in the Management of Fundic Gland Polyps.
    J Gastroenterol Hepatol. 2025;40:1374-1380.
    PubMed     Abstract available
    
    
    
43. XIE X, Su J, Wang W, Wei H, et al
    Trends in Stomach Cancer Burden in China: A Joinpoint and APC Analysis Based on GBD 2021.
    J Gastroenterol Hepatol. 2025;40:1500-1514.
    PubMed     Abstract available
    
    
    May 2025
44. SHIBATA H, Fujiyoshi T, Kawata N, Obayashi T, et al
    Vonoprazan or Proton Pump Inhibitor for Gastric Endoscopic Submucosal Dissection in Patients Taking Antithrombotic Agents.
    J Gastroenterol Hepatol. 2025 May 27. doi: 10.1111/jgh.17027.
    PubMed     Abstract available
    
    
    
45. YOUNG E, Wan N, Philpott H, Singh R, et al
    The West Catching Up With the East: High-Magnification NBI Is Accurate for the Diagnosis of Gastric Neoplasia in a Western Population.
    J Gastroenterol Hepatol. 2025;40:1128-1134.
    PubMed     Abstract available
    
    
    April 2025
46. WANG M, Guo Y, Xu Y, Yu Y, et al
    Unraveling the Role of Programmed Cell Death Gene Signature and THBS1 in Gastric Cancer Progression and Therapy Response.
    J Gastroenterol Hepatol. 2025 Apr 28. doi: 10.1111/jgh.16987.
    PubMed     Abstract available
    
    
    
47. PITTAYANON R, Tiankanon K, Faknak N, Lerttanatum N, et al
    Efficacy of Radiofrequency Ablation as a Treatment for High-Risk Gastric Intestinal Metaplasia: A Randomized, Self-Control Study.
    J Gastroenterol Hepatol. 2025;40:891-899.
    PubMed     Abstract available
    
    
    March 2025
48. 
    NOTIFICATION: MiR-876-3p Regulates Cisplatin Resistance and Stem Cell-like Properties of Gastric Cancer Cells by Targeting TMED3.
    J Gastroenterol Hepatol. 2025 Mar 13. doi: 10.1111/jgh.16919.
    PubMed    
    
    
    February 2025
49. HARA K, Kawara F, Yamanaka K, Nishioka C, et al
    Gastrointestinal: White Granules in the Stomach Caused by Lymphangitis Carcinomatosis From Signet-Ring Cell Gastric Carcinoma.
    J Gastroenterol Hepatol. 2025 Feb 6. doi: 10.1111/jgh.16894.
    PubMed    
    
    
    December 2024
50. HUANG L, Feng B, Yang Z, Feng ST, et al
    A Transfer Learning Radiomics Nomogram to Predict the Postoperative Recurrence of Advanced Gastric Cancer.
    J Gastroenterol Hepatol. 2024 Dec 27. doi: 10.1111/jgh.16863.
    PubMed     Abstract available
    
    
    
51. OTANI K, Hang DV, Pittayanon R, Liu H, et al
    Asia-Pacific Survey on the Management of Helicobacter pylori Infection.
    J Gastroenterol Hepatol. 2024 Dec 26. doi: 10.1111/jgh.16862.
    PubMed     Abstract available
    
    
    
52. MATSUEDA K, Kono Y, Miyahara K, Nakagawa M, et al
    Clinical Significance of Lymphatic Involvement in Intramucosal (pT1a) Gastric Cancer Resected by Endoscopic Submucosal Dissection.
    J Gastroenterol Hepatol. 2024 Dec 18. doi: 10.1111/jgh.16854.
    PubMed     Abstract available
    
    
    
53. PAKNESHAN S, Moy N, Shah A, Koloski N, et al
    Post-colonoscopy upper gastrointestinal malignancies in positive immunochemical fecal occult blood test patients: An Australian data linkage study.
    J Gastroenterol Hepatol. 2024;39:2811-2816.
    PubMed     Abstract available
    
    
    
54. HUANG L, Xu M, Li Y, Dong Z, et al
    Gastric neoplasm detection of computer-aided detection-assisted esophagogastroduodenoscopy changes with implement scenarios: a real-world study.
    J Gastroenterol Hepatol. 2024;39:2787-2795.
    PubMed     Abstract available
    
    
    
55. HIRATA S, Hamada K, Iwamuro M, Mouri H, et al
    Rates and risk factors of bleeding after gastric endoscopic submucosal dissection with continuous warfarin or 1-day withdrawal of direct oral anticoagulants.
    J Gastroenterol Hepatol. 2024;39:2760-2766.
    PubMed     Abstract available
    
    
    September 2024
56. DANPANICHKUL P, Auttapracha T, Kongarin S, Ponvilawan B, et al
    Global epidemiology of early-onset upper gastrointestinal cancer: trend from the Global Burden of Disease Study 2019.
    J Gastroenterol Hepatol. 2024;39:1856-1868.
    PubMed     Abstract available
    
    
    August 2024
57. ISHIBASHI F, Suzuki S, Kobayashi K, Tanaka R, et al
    Cost-effective endoscopic screening for gastric cancer in a cohort with low Helicobacter pylori prevalence.
    J Gastroenterol Hepatol. 2024 Aug 9. doi: 10.1111/jgh.16715.
    PubMed     Abstract available
    
    
    
58. HAYASAKA J, Hoteya S, Takazawa Y, Kikuchi D, et al
    Antacids and reflux esophagitis as a risk factor for gastric neoplasm of fundic-gland type: A retrospective, matched case-control study.
    J Gastroenterol Hepatol. 2024;39:1580-1585.
    PubMed     Abstract available
    
    
    July 2024
59. CHANTAROJANASIRI T, Sonthalia N, Lui RN
    Small gastric subepithelial lesions: A sand in the eye.
    J Gastroenterol Hepatol. 2024;39:1207-1209.
    PubMed    
    
    
    
60. GENG ZH, Qu YF, Fu PY, Zhu Y, et al
    A scoring system to predict the technical difficulty of endoscopic resection for cardial submucosal tumors.
    J Gastroenterol Hepatol. 2024;39:1352-1357.
    PubMed     Abstract available
    
    
    
61. MIMURA T, Yamamoto Y, Suzuki H, Takizawa K, et al
    Risk factors for intraoperative and delayed perforation related with gastric endoscopic submucosal dissection.
    J Gastroenterol Hepatol. 2024;39:1358-1366.
    PubMed     Abstract available
    
    
    
62. FUJITA M, Yamaguchi K, Nagashima K, Suzuki K, et al
    Impact of the COVID-19 pandemic on gastric surgery in Japan: A nationwide study using interrupted time-series analyses.
    J Gastroenterol Hepatol. 2024;39:1277-1284.
    PubMed     Abstract available
    
    
    
63. KOBAYASHI R, Hirasawa K, Ozeki Y, Sawada A, et al
    Clinical course of small gastric subepithelial lesion less than 20 mm diagnosed by endoscopic ultrasound-guided fine-needle aspiration.
    J Gastroenterol Hepatol. 2024;39:1285-1290.
    PubMed     Abstract available
    
    
    
64. ZENG X, Yang L, Dong Z, Gong D, et al
    The effect of incorporating domain knowledge with deep learning in identifying benign and malignant gastric whitish lesions: A retrospective study.
    J Gastroenterol Hepatol. 2024;39:1343-1351.
    PubMed     Abstract available
    
    
    June 2024
65. LI M, He W, Wang F, Zhang P, et al
    High expression of NOTCH2 in gastric adenocarcinoma: A novel early diagnostic target.
    J Gastroenterol Hepatol. 2024;39:1115-1122.
    PubMed     Abstract available
    
    
    
66. CHEUNG KS
    Big data approach in the field of gastric and colorectal cancer research.
    J Gastroenterol Hepatol. 2024;39:1027-1032.
    PubMed     Abstract available
    
    
    
67. CHEN L, Jin T, Fang Y, Wu G, et al
    Comparison of postoperative survival between early-onset and late-onset adenocarcinoma of esophagogastric junction: a population-based study.
    J Gastroenterol Hepatol. 2024;39:1073-1081.
    PubMed     Abstract available
    
    
    May 2024
68. KAWAMURA M, Uedo N, Yao K, Koike T, et al
    Endoscopic and histological risk stratification for gastric cancer using gastric intestinal metaplasia.
    J Gastroenterol Hepatol. 2024 May 13. doi: 10.1111/jgh.16617.
    PubMed     Abstract available
    
    
    
69. CHO JH, Jin SY, Park S
    Carbon footprint and cost reduction by endoscopic grading of gastric intestinal metaplasia using narrow-band imaging.
    J Gastroenterol Hepatol. 2024;39:942-948.
    PubMed     Abstract available
    
    
    
70. TANI Y, Li JW, Uedo N
    Gastrointestinal: Texture and color enhancement imaging is useful for detection of small gastric adenocarcinoma of fundic-gland type.
    J Gastroenterol Hepatol. 2024;39:783-784.
    PubMed    
    
    
    April 2024
71. ASONUMA S, Hatta W, Koike T, Okata H, et al
    Risk stratification of synchronous gastric cancers including alcohol-related genetic polymorphisms.
    J Gastroenterol Hepatol. 2024 Apr 16. doi: 10.1111/jgh.16570.
    PubMed     Abstract available
    
    
    
72. ZHAN ZQ, Chen YZ, Huang ZM, Luo YH, et al
    Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta-analysis of 31 prospective cohorts and Mendelian randomization study.
    J Gastroenterol Hepatol. 2024;39:630-641.
    PubMed     Abstract available
    
    
    
73. WANG Z, He D, Yang JL
    Gastrointestinal: Chronic anemia caused by diffuse lesions of the stomach.
    J Gastroenterol Hepatol. 2024;39:615-616.
    PubMed    
    
    
    March 2024
74. GU L, Wang X, Ouyang M, Li F, et al
    Facilitating endoscopic full-thickness resection for gastric submucosal tumors with a novel snare traction method (with video).
    J Gastroenterol Hepatol. 2024;39:535-543.
    PubMed     Abstract available
    
    
    November 2023
75. DONG X, Chen X, Zhao Y, Wu Q, et al
    CircTMEM87A promotes the tumorigenesis of gastric cancer by regulating the miR-1276/SLC7A11 axis.
    J Gastroenterol Hepatol. 2023 Nov 30. doi: 10.1111/jgh.16402.
    PubMed     Abstract available
    
    
    
76. TANAKA K, Baba Y
    Gastrointestinal: Diminutive Epstein-Barr virus-associated gastric carcinoma.
    J Gastroenterol Hepatol. 2023 Nov 16. doi: 10.1111/jgh.16410.
    PubMed    
    
    
    October 2023
77. MATSUEDA K, Uedo N, Kitamura M, Shichijo S, et al
    Endoscopic features of gastric neuroendocrine carcinoma.
    J Gastroenterol Hepatol. 2023;38:1808-1817.
    PubMed     Abstract available
    
    
    
78. JUNG YS, Tran MTX, Park B, Moon CM, et al
    Mutual association between family history of gastric and colorectal cancer and risk of gastric and colorectal cancer.
    J Gastroenterol Hepatol. 2023;38:1787-1793.
    PubMed     Abstract available
    
    
    September 2023
79. QUEK SXZ, Lee JWJ, Feng Z, Soh MM, et al
    Comparing artificial intelligence to humans for endoscopic diagnosis of gastric neoplasia: An external validation study.
    J Gastroenterol Hepatol. 2023;38:1587-1591.
    PubMed     Abstract available
    
    
    August 2023
80. ZHANG P, Xu T, Wang J, Li Y, et al
    Comparison of different risk stratifications for gastric cancer and establishing a simplified risk-scoring model based on the Kyoto classification.
    J Gastroenterol Hepatol. 2023 Aug 24. doi: 10.1111/jgh.16324.
    PubMed     Abstract available
    
    
    June 2023
81. KAWASAKI K, Torisu T, Esaki M, Eizuka M, et al
    Continuous use of antithrombotic medications during peri-endoscopic submucosal dissection period for colorectal lesions: A propensity score matched study.
    J Gastroenterol Hepatol. 2023;38:955-961.
    PubMed     Abstract available
    
    
    
82. LIU J, Xiang Y, Tang D, Xu G, et al
    Gastrointestinal: A case of type 1 gastric neuroendocrine tumor with multiple endocrine neoplasia type 1.
    J Gastroenterol Hepatol. 2023;38:842.
    PubMed    
    
    
    May 2023
83. TANAKA T, Miwa K, Shimotsuura Y, Nagasu S, et al
    High intramuscular adipose tissue content was a favorable prognostic factor in patients with advanced gastric cancer treated with nivolumab monotherapy.
    J Gastroenterol Hepatol. 2023 May 24. doi: 10.1111/jgh.16239.
    PubMed     Abstract available
    
    
    
84. HIGASHINO M, Ono S, Matsumoto S, Kubo M, et al
    Improvement of detection sensitivity of upper gastrointestinal epithelial neoplasia in linked color imaging based on data of eye tracking.
    J Gastroenterol Hepatol. 2023;38:710-715.
    PubMed     Abstract available
    
    
    April 2023
85. CHEN N, Hu Y, Huang RZ, Chen DL, et al
    Circular RNA circTNIK promotes tumor progression and metastasis in gastric cancer by regulating ZEB2.
    J Gastroenterol Hepatol. 2023 Apr 20. doi: 10.1111/jgh.16189.
    PubMed     Abstract available
    
    
    March 2023
86. NIE X, Zhao C, Zhang Y, Huang W, et al
    Nucleolar protein TCOF1 maintains gastric cancer cell proliferation by regulating R-loop associated DNA replication stress.
    J Gastroenterol Hepatol. 2023 Mar 20. doi: 10.1111/jgh.16181.
    PubMed     Abstract available
    
    
    
87. MATSUURA N, Kato M, Irino T, Hirata K, et al
    Gastrointestinal: Ten-millimeter advanced duodenal cancer with a gastric phenotype.
    J Gastroenterol Hepatol. 2023;38:347.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum